Skip to main content
Top
Published in: Acta Diabetologica 3/2024

21-11-2023 | Diabetic Retinopathy | Original Article

Retinal age gap as a predictive biomarker for future risk of clinically significant diabetic retinopathy

Authors: Ruiye Chen, Yanping Chen, Junyao Zhang, Wei Wang, Wenyi Hu, Mingguang He, Zhuoting Zhu

Published in: Acta Diabetologica | Issue 3/2024

Login to get access

Abstract

Aims

Retinal age derived from fundus images has been verified as a novel ageing biomarker. We aim to explore the association between retinal age gap (retinal age minus chronological age) and incident diabetic retinopathy (DR).

Methods

Retinal age prediction was performed by a deep learning model, trained and validated based on 19,200 fundus images of 11,052 disease-free participants. Retinal age gaps were determined for 2311 patients with diabetes who had no history of diabetic retinopathy at baseline. DR events were ascertained by data linkage to hospital admissions. Cox proportional hazards regression models were performed to evaluate the association between retinal age gaps and incident DR.

Results

During the median follow-up period of 11.0 (interquartile range: 10.8–11.1) years, 183 of 2311 participants with diabetes developed incident DR. Each additional year of the retinal age gap was associated with a 7% increase in the risk of incident DR (hazard ratio [HR] = 1.07, 95% confidence interval [CI] 1.02–1.12, P = 0.004), after adjusting for confounding factors. Participants with retinal age gaps in the fourth quartile had a significantly higher DR risk compared to participants with retinal age gaps in the lowest quartile (HR = 2.88, 95% CI 1.61–5.15, P < 0.001).

Conclusions

We found that higher retinal age gap was associated with an increased risk of incident DR. As an easy and non-invasive biomarker, the retinal age gap may serve as an informative tool to facilitate the individualized risk assessment and personalized screening protocol for DR.
Literature
1.
go back to reference Diabetes ETL (2020) Under the lens: diabetic retinopathy. Lancet Diabetes Endocrinol 8(11):869CrossRef Diabetes ETL (2020) Under the lens: diabetic retinopathy. Lancet Diabetes Endocrinol 8(11):869CrossRef
2.
go back to reference Teo ZL, Tham YC, Yu M et al (2021) Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology 128(11):1580–1591PubMedCrossRef Teo ZL, Tham YC, Yu M et al (2021) Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology 128(11):1580–1591PubMedCrossRef
3.
go back to reference Vujosevic S, Aldington SJ, Silva P et al (2020) Screening for diabetic retinopathy: new perspectives and challenges. Lancet Diabetes Endocrinol 8(4):337–347PubMedCrossRef Vujosevic S, Aldington SJ, Silva P et al (2020) Screening for diabetic retinopathy: new perspectives and challenges. Lancet Diabetes Endocrinol 8(4):337–347PubMedCrossRef
4.
go back to reference Jampol LM, Glassman AR, Sun J (2020) Evaluation and care of patients with diabetic retinopathy. N Engl J Med 382(17):1629–1637PubMedCrossRef Jampol LM, Glassman AR, Sun J (2020) Evaluation and care of patients with diabetic retinopathy. N Engl J Med 382(17):1629–1637PubMedCrossRef
5.
go back to reference Coney JM (2019) Addressing unmet needs in diabetic retinopathy. Am J Manag Care 25(16 Suppl):S311–S316PubMed Coney JM (2019) Addressing unmet needs in diabetic retinopathy. Am J Manag Care 25(16 Suppl):S311–S316PubMed
6.
go back to reference Early photocoagulation for diabetic retinopathy. ETDRS report number 9 (1991) Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 98(5 Suppl):766–85 Early photocoagulation for diabetic retinopathy. ETDRS report number 9 (1991) Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 98(5 Suppl):766–85
7.
go back to reference Photocoagulation treatment of proliferative diabetic retinopathy (1978) the second report of diabetic retinopathy study findings. Ophthalmology 85(1):82–106CrossRef Photocoagulation treatment of proliferative diabetic retinopathy (1978) the second report of diabetic retinopathy study findings. Ophthalmology 85(1):82–106CrossRef
8.
go back to reference Javitt JC, Aiello LP (1996) Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med 124(1 Pt 2):164–169PubMedCrossRef Javitt JC, Aiello LP (1996) Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med 124(1 Pt 2):164–169PubMedCrossRef
9.
go back to reference Javitt JC (1995) Cost savings associated with detection and treatment of diabetic eye disease. Pharmacoeconomics 8(Suppl 1):33–39PubMedCrossRef Javitt JC (1995) Cost savings associated with detection and treatment of diabetic eye disease. Pharmacoeconomics 8(Suppl 1):33–39PubMedCrossRef
10.
11.
go back to reference Larsen MB, Henriksen JE, Grauslund J, Peto T (2017) Prevalence and risk factors for diabetic retinopathy in 17 152 patients from the island of Funen. Den Acta Ophthalmol 95(8):778–786CrossRef Larsen MB, Henriksen JE, Grauslund J, Peto T (2017) Prevalence and risk factors for diabetic retinopathy in 17 152 patients from the island of Funen. Den Acta Ophthalmol 95(8):778–786CrossRef
12.
go back to reference Al-Rubeaan K, Abu El-Asrar AM, Youssef AM et al (2015) Diabetic retinopathy and its risk factors in a society with a type 2 diabetes epidemic: a Saudi national diabetes registry-based study. Acta Ophthalmol 93(2):e140–e147PubMedCrossRef Al-Rubeaan K, Abu El-Asrar AM, Youssef AM et al (2015) Diabetic retinopathy and its risk factors in a society with a type 2 diabetes epidemic: a Saudi national diabetes registry-based study. Acta Ophthalmol 93(2):e140–e147PubMedCrossRef
13.
go back to reference Namperumalsamy P, Kim R, Vignesh TP et al (2009) Prevalence and risk factors for diabetic retinopathy: a population-based assessment from Theni District, south India. Br J Ophthalmol 93(4):429–434PubMed Namperumalsamy P, Kim R, Vignesh TP et al (2009) Prevalence and risk factors for diabetic retinopathy: a population-based assessment from Theni District, south India. Br J Ophthalmol 93(4):429–434PubMed
15.
go back to reference Maghbooli Z, Hossein-nezhad A, Larijani B, Amini M, Keshtkar A (2015) Global DNA methylation as a possible biomarker for diabetic retinopathy. Diabetes Metab Res Rev 31(2):183–189PubMedCrossRef Maghbooli Z, Hossein-nezhad A, Larijani B, Amini M, Keshtkar A (2015) Global DNA methylation as a possible biomarker for diabetic retinopathy. Diabetes Metab Res Rev 31(2):183–189PubMedCrossRef
16.
go back to reference Zhu Z, Shi D, Guankai P et al (2022) Retinal age gap as a predictive biomarker for mortality risk. Br J Ophthalmol 107(4):547–554PubMedCrossRef Zhu Z, Shi D, Guankai P et al (2022) Retinal age gap as a predictive biomarker for mortality risk. Br J Ophthalmol 107(4):547–554PubMedCrossRef
17.
20.
go back to reference Zhang S, Chen R, Wang Y et al (2023) Association of Retinal Age Gap and Risk of Kidney Failure: A UK Biobank Study. Am J Kidney Dis 81(5):537–44PubMedCrossRef Zhang S, Chen R, Wang Y et al (2023) Association of Retinal Age Gap and Risk of Kidney Failure: A UK Biobank Study. Am J Kidney Dis 81(5):537–44PubMedCrossRef
21.
go back to reference Chen R, Xu J, Shang X et al. (2023) Association between cardiovascular health metrics and retinal ageing. Geroscience Chen R, Xu J, Shang X et al. (2023) Association between cardiovascular health metrics and retinal ageing. Geroscience
22.
go back to reference Sudlow C, Gallacher J, Allen N et al (2015) UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med 12(3):e1001779PubMedPubMedCentralCrossRef Sudlow C, Gallacher J, Allen N et al (2015) UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med 12(3):e1001779PubMedPubMedCentralCrossRef
23.
25.
go back to reference Rao H, Jalali JA, Johnston TP, Koulen P (2021) Emerging roles of dyslipidemia and hyperglycemia in diabetic retinopathy: molecular mechanisms and clinical perspectives. Front Endocrinol (Lausanne) 12:620045PubMedCrossRef Rao H, Jalali JA, Johnston TP, Koulen P (2021) Emerging roles of dyslipidemia and hyperglycemia in diabetic retinopathy: molecular mechanisms and clinical perspectives. Front Endocrinol (Lausanne) 12:620045PubMedCrossRef
26.
go back to reference Flaxel CJ, Adelman RA, Bailey ST et al (2020) Diabetic retinopathy preferred practice pattern(R). Ophthalmology 127(1):P66–P145PubMedCrossRef Flaxel CJ, Adelman RA, Bailey ST et al (2020) Diabetic retinopathy preferred practice pattern(R). Ophthalmology 127(1):P66–P145PubMedCrossRef
28.
29.
go back to reference Wu J, Liu LL, Cao M et al (2021) DNA methylation plays important roles in retinal development and diseases. Exp Eye Res 211:108733PubMedCrossRef Wu J, Liu LL, Cao M et al (2021) DNA methylation plays important roles in retinal development and diseases. Exp Eye Res 211:108733PubMedCrossRef
30.
go back to reference van der Heijden AA, Nijpels G, Badloe F et al (2020) Prediction models for development of retinopathy in people with type 2 diabetes: systematic review and external validation in a Dutch primary care setting. Diabetologia 63(6):1110–1119PubMedPubMedCentralCrossRef van der Heijden AA, Nijpels G, Badloe F et al (2020) Prediction models for development of retinopathy in people with type 2 diabetes: systematic review and external validation in a Dutch primary care setting. Diabetologia 63(6):1110–1119PubMedPubMedCentralCrossRef
31.
go back to reference Scanlon PH, Aldington SJ, Leal J et al (2015) Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening. Health Technol Assess 19(74):1–116PubMedPubMedCentralCrossRef Scanlon PH, Aldington SJ, Leal J et al (2015) Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening. Health Technol Assess 19(74):1–116PubMedPubMedCentralCrossRef
32.
go back to reference Nazari Khanamiri H, Nakatsuka A, El-Annan J (2017) Smartphone Fundus Photography. J Vis Exp 125:e55958 Nazari Khanamiri H, Nakatsuka A, El-Annan J (2017) Smartphone Fundus Photography. J Vis Exp 125:e55958
34.
go back to reference Xu H, Chen M, Forrester JV (2009) Para-inflammation in the aging retina. Prog Retin Eye Res 28(5):348–368PubMedCrossRef Xu H, Chen M, Forrester JV (2009) Para-inflammation in the aging retina. Prog Retin Eye Res 28(5):348–368PubMedCrossRef
35.
go back to reference Soni D, Sagar P, Takkar B (2021) Diabetic retinal neurodegeneration as a form of diabetic retinopathy. Int Ophthalmol 41(9):3223–3248PubMedCrossRef Soni D, Sagar P, Takkar B (2021) Diabetic retinal neurodegeneration as a form of diabetic retinopathy. Int Ophthalmol 41(9):3223–3248PubMedCrossRef
36.
go back to reference Picconi F, Parravano M, Ylli D et al (2017) Retinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability. Acta Diabetol 54(5):489–497PubMedPubMedCentralCrossRef Picconi F, Parravano M, Ylli D et al (2017) Retinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability. Acta Diabetol 54(5):489–497PubMedPubMedCentralCrossRef
37.
go back to reference Sohn EH, van Dijk HW, Jiao C et al (2016) Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus. Proc Natl Acad Sci U S A 113(19):E2655–E2664PubMedPubMedCentralCrossRef Sohn EH, van Dijk HW, Jiao C et al (2016) Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus. Proc Natl Acad Sci U S A 113(19):E2655–E2664PubMedPubMedCentralCrossRef
38.
go back to reference Tang Z, Chan MY, Leung WY et al (2021) Assessment of retinal neurodegeneration with spectral-domain optical coherence tomography: a systematic review and meta-analysis. Eye (Lond) 35(5):1317–1325PubMedCrossRef Tang Z, Chan MY, Leung WY et al (2021) Assessment of retinal neurodegeneration with spectral-domain optical coherence tomography: a systematic review and meta-analysis. Eye (Lond) 35(5):1317–1325PubMedCrossRef
39.
go back to reference Santos AR, Ribeiro L, Bandello F et al (2017) Functional and structural findings of neurodegeneration in early stages of diabetic retinopathy: cross-sectional analyses of baseline data of the EUROCONDOR project. Diabetes 66(9):2503–2510PubMedCrossRef Santos AR, Ribeiro L, Bandello F et al (2017) Functional and structural findings of neurodegeneration in early stages of diabetic retinopathy: cross-sectional analyses of baseline data of the EUROCONDOR project. Diabetes 66(9):2503–2510PubMedCrossRef
40.
go back to reference Kadlubowska J, Malaguarnera L, Waz P, Zorena K (2016) Neurodegeneration and neuroinflammation in diabetic retinopathy: potential approaches to delay neuronal loss. Curr Neuropharmacol 14(8):831–839PubMedPubMedCentralCrossRef Kadlubowska J, Malaguarnera L, Waz P, Zorena K (2016) Neurodegeneration and neuroinflammation in diabetic retinopathy: potential approaches to delay neuronal loss. Curr Neuropharmacol 14(8):831–839PubMedPubMedCentralCrossRef
41.
go back to reference Lecleire-Collet A, Audo I, Aout M et al (2011) Evaluation of retinal function and flicker light-induced retinal vascular response in normotensive patients with diabetes without retinopathy. Invest Ophthalmol Vis Sci 52(6):2861–2867PubMedCrossRef Lecleire-Collet A, Audo I, Aout M et al (2011) Evaluation of retinal function and flicker light-induced retinal vascular response in normotensive patients with diabetes without retinopathy. Invest Ophthalmol Vis Sci 52(6):2861–2867PubMedCrossRef
42.
go back to reference Ng JS, Bearse MA Jr, Schneck ME, Barez S, Adams AJ (2008) Local diabetic retinopathy prediction by multifocal ERG delays over 3 years. Invest Ophthalmol Vis Sci 49(4):1622–1628PubMedCrossRef Ng JS, Bearse MA Jr, Schneck ME, Barez S, Adams AJ (2008) Local diabetic retinopathy prediction by multifocal ERG delays over 3 years. Invest Ophthalmol Vis Sci 49(4):1622–1628PubMedCrossRef
43.
go back to reference Han Y, Adams AJ, Bearse MA Jr, Schneck ME (2004) Multifocal electroretinogram and short-wavelength automated perimetry measures in diabetic eyes with little or no retinopathy. Arch Ophthalmol 122(12):1809–1815PubMedCrossRef Han Y, Adams AJ, Bearse MA Jr, Schneck ME (2004) Multifocal electroretinogram and short-wavelength automated perimetry measures in diabetic eyes with little or no retinopathy. Arch Ophthalmol 122(12):1809–1815PubMedCrossRef
44.
go back to reference Lee KS, Lin S, Copland DA, Dick AD, Liu J (2021) Cellular senescence in the aging retina and developments of senotherapies for age-related macular degeneration. J Neuroinflammation 18(1):32PubMedPubMedCentralCrossRef Lee KS, Lin S, Copland DA, Dick AD, Liu J (2021) Cellular senescence in the aging retina and developments of senotherapies for age-related macular degeneration. J Neuroinflammation 18(1):32PubMedPubMedCentralCrossRef
45.
46.
go back to reference Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) (1998) UK prospective diabetes study (UKPDS) group. Lancet 352(9131):837–53PubMed Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) (1998) UK prospective diabetes study (UKPDS) group. Lancet 352(9131):837–53PubMed
47.
go back to reference Diabetes C, Complications Trial Research G, Nathan DM et al (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329(14):977–86CrossRef Diabetes C, Complications Trial Research G, Nathan DM et al (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329(14):977–86CrossRef
48.
go back to reference Tan GS, Cheung N, Simo R, Cheung GC, Wong TY (2017) Diabetic macular oedema. Lancet Diabetes Endocrinol 5(2):143–155PubMedCrossRef Tan GS, Cheung N, Simo R, Cheung GC, Wong TY (2017) Diabetic macular oedema. Lancet Diabetes Endocrinol 5(2):143–155PubMedCrossRef
Metadata
Title
Retinal age gap as a predictive biomarker for future risk of clinically significant diabetic retinopathy
Authors
Ruiye Chen
Yanping Chen
Junyao Zhang
Wei Wang
Wenyi Hu
Mingguang He
Zhuoting Zhu
Publication date
21-11-2023
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 3/2024
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-023-02199-5

Other articles of this Issue 3/2024

Acta Diabetologica 3/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine